With the FDA tightening its guidance around the production of nonbacterial beta-lactam drugs, Swedish CDMO Recipharm is touting new efforts to stay in compliance—and a new partnership. Juggling a mix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results